<span class="paragraphSection">Patients undergoing ophthalmic procedures, including cataract, glaucoma, and vitreoretinal surgeries, are often elderly with significant co-morbidities. Regional anaesthesia (RA) techniques are commonly used unless general anaesthesia is preferred or specifically indicated. Some of these patients may be receiving antithrombotics for serious medical conditions. Antithrombotics are drugs that reduce blood clot formation, such as aspirin, oral anticoagulants, antiplatelet agents, or novel oral anticoagulants (NOACs). Clinical effects of some antithrombotics with longer half-lifes may take days to wane. Time may not be available to stop these agents if surgery is urgent; therefore, specific measures are undertaken to antagonize their effects.</span>
http://ift.tt/2jEIbbi
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,
Ετικέτες
Πέμπτη 19 Ιανουαρίου 2017
Stopping antithrombotics during regional anaesthesia and eye surgery: crying wolf?
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Publication date: September 2017 Source: European Journal of Surgical Oncology (EJSO), Volume 43, Issue 9 http://ift.tt/2gezJ2D
-
Publication date: January–February 2018 Source: Materials Today, Volume 21, Issue 1 Author(s): David Bradley http://ift.tt/2BP...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου